Precigen is a cutting-edge biopharmaceutical company based in South San Francisco, CA, dedicated to advancing gene and cell therapies for immuno-oncology, autoimmune disorders, and infectious diseases. Utilizing precision technology, Precigen focuses on developing innovative and affordable biotherapeutics to address urgent medical needs.
With a strong emphasis on research and clinical development, Precigen operates as an innovation engine, driving forward a diverse pipeline of unique therapies towards clinical proof-of-concept and commercialization. Their approach combines non-viral and viral expression systems, genome engineering, and precision bioengineering switch technologies to deliver potent and safe gene and cellular therapies with enhanced efficacy.
Generated from the website
